ArticleMedicine international
Effectiveness of Tamaru method plasma therapy: Overview and the original method.
Article in Medicine international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid aging of the population in Japan has led to an increased incidence of cancer, creating a demand for effective therapeutic options with minimal physical and financial burden. Non-equilibrium atmospheric pressure plasma (NEAPP), or low-temperature plasma, has emerged as a promising modality in oncology. The present study summarizes the fundamental principles of NEAPP and its therapeutic applications in cancer treatment. The authors first provide an overview of established approaches, such as the direct irradiation of cancer cells and the indirect use of plasma-activated medium, which have been shown to induce apoptosis in malignant cells. Subsequently, the authors introduce a novel therapeutic system, the Tamaru Method Plasma Therapy, developed by the authors' research group. This system combines a unique plasma-generating device, termed Plasma AIAS, with the oral intake of plasma-activated water. The proposed mechanism of this non-invasive method is the systemic enhancement of intracellular adenosine triphosphate production and the generation of nitric oxide. This dual action is expected to improve microcirculation and exert anti-tumor effects, while maintaining a high safety profile. The present study highlights the potential of this original method as a next-generation therapy for cancer, addressing the needs of modern medical care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.